Bidirectional influences of acetazolamide on central nervous system oxygen toxicity of rats

Undersea and Hyperbaric Medicine

Volumn 37, Issue 5, 2010, Pages 271-280

  Huang, Jun Long ^a   Zhang, You Lei ^b   Xiao, Xiang ^a   Zhanzg, John H ^c   Lian, Qing Lin ^a   Liu, Yun ^a   Sun, Xue Jun ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b Eastern Hepatobiliary Surgery Hospital   (China)

^c LOMA LINDA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ALDEHYDE; ANTICONVULSIVE AGENT; CARBONATE DEHYDRATASE; CARBONATE DEHYDRATASE INHIBITOR; MALEALDEHYDE; OXYGEN; VASODILATOR AGENT;

AIR QUALITY CONTROL; ANIMAL; ARTICLE; ATMOSPHERIC PRESSURE; BODY WEIGHT; BRAIN; BRAIN CIRCULATION; CENTRAL NERVOUS SYSTEM; DOSE RESPONSE; DRUG EFFECT; ELECTRODE; ELECTROENCEPHALOGRAPHY; HYPERBARIC OXYGEN; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; METABOLISM; PHYSIOLOGY; RANDOMIZATION; RAT; SPRAGUE DAWLEY RAT; TIME; VASCULARIZATION;

ACETAZOLAMIDE; ALDEHYDES; ANIMALS; ANTICONVULSANTS; ATMOSPHERE EXPOSURE CHAMBERS; ATMOSPHERIC PRESSURE; BODY WEIGHT; BRAIN; CARBONIC ANHYDRASE INHIBITORS; CARBONIC ANHYDRASES; CENTRAL NERVOUS SYSTEM; CEREBROVASCULAR CIRCULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRODES, IMPLANTED; ELECTROENCEPHALOGRAPHY; HYPERBARIC OXYGENATION; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENTRICULAR; MALE; OXYGEN; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; VASODILATOR AGENTS;

EID: 78149246126     PISSN: 10662936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Harabin AL, Survanshi SS, Homer LD. A model for predicting central nervous system oxygen toxicity from hyperbaric oxygen exposures in humans. Toxicol Appl Pharmacol. 1995; 132: 19-26.
2. Thorn SR. Applications of pressure biology: toxic and beneficial effects of oxygen. In Basic and Applied High Pressure Biology, P.B. Bennett, R.E. Marquis, eds. University of Rochester Press, Rochester, 1994: 365-373
3. Whelan HT, Bajic DM, Karlovits SM, Houle JM, Kindwall EP. Use of cytochrome-P450 monooxygenase 2 El isozyme inhibitors to delay seizures caused by central nervous system oxygen toxicity. Aviat Space Environ Med. 1998; 69: 480-485.
4. Rockswold SB, Rockswold GL, Defillo A. Hyperbaric oxygen in traumatic brain injury. Neurol Res. 2007; 29: 162-172.
5. Huang KC, Hsu WH, Peng KT, Huang TJ, Hsu RW. Hyperbaric oxygen therapy in orthopedic conditions: an evaluation of safety. J Trauma. 2006; 61: 913-917.
6. Plafki C, Peters P, Almeling M, Welslau W, Busch R. Complications and side effects of hyperbaric oxygen therapy. Aviat Space Environ Med. 2000; 71 : 119-124.
7. Muller-Bolla M, Collet JP, Ducruet T, Robinson A. Side effects of hyperbaric oxygen therapy in children with cerebral palsy. Undersea Hyperb Med. 2006; 33: 237-244.
8. Chavko M, Braisted JC, Outsa NJ, Harabin AL. Role of cerebral blood flow in seizures from hyperbaric oxygen exposure. Brain Res. 1998; 791: 75-82.
9. Kurasako T, Takeda Y, Hirakawa M. Increase in cerebral blood flow as a predictor of hyperbaric oxygen-induced convulsion in artificially ventilated rats. Acta Med Okayama. 2000; 54: 15-20.
10. Sato T, Resor SR, Resor LD, Woodbury DM, Kemp JW. Acetazolamide. In Antiepileptic drugs, 4th ed, R.H. Levy, R.H. Mattson, B.S. Meldrum, eds. Raven Press, New Yourk, 1995: 969-985.
11. Beckman DL, Crittenden DJ. Protection from oxygen-induced seizures by clonazepam and propylene glycol. Proc Soc Exp Biol Med. 1981; 168: 45-48.
12. Criborn CO, Clemedson CJ, Henriksson C. Amphetamine as a protective agent against oxygeninduced convulsions in mice. Aviat Space Environ Med. 1986; 57: 777-781.
13. Wood CD. Acetazolamide and CO2 in hyperbaric oxygen toxicity. Undersea Biomedical Research. 1982; 9: 15-20.
14. Halliwell B, Gutteridge JM. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J. 1984; 219: 1-14.
15. Bostek CC. Oxygen toxicity: an introduction. AANAJ. 1989; 57: 231-237.
16. Bitterman N, Bitterman H. L-arginine-NO pathway and CNS oxygen toxicity. J Appl Physiol. 1998; 84: 1633-1638.
17. Oles KS, Penry JK, Cole DL, Howard G. Use of acetazolamide as an adjunct to carbamazepine in refractory partial seizures. Epilepsia. 1989; 30: 74-78.
18. Bergstom WH, Carzoli RF, Lombroso C, Davidson DT, Wallace WM. Observations on metabolic and clinical effects of carbonic anhydrase inhibitors in epileptics. Am J Dis Child. 1952; 84: 71-73.
19. Reiss WG, Oles KS. Acetazolamide in the treatment of seizures. Ann Pharmacother. 1996; 30: 514-519.
20. Lassen NA, Friberg L, Kastrup J, Rizzi D and Jensen JJ. Effects of acetazolamide on cerebral blood flow and brain tissue oxygenation. Postgraduate Medical Journal. 1987; 63: 185-187.
21. Gutsaeva DR, Moskvin AN, Zhiliaev SIu, Kostkin VB, Demchenko IT. Nitric oxide and carbon dioxide in neurotoxicity induced by oxygen under pressure. Ross Fiziol ZhTm IM Sechenova. 2004; 90: 428-436.
22. Weaver LK, Howe S. Normobaric measurement of arterial oxygen tension of subjects exposed to hyperbaric oxygen. Chest. 1992; 102: 1175-1181.
23. Taraldsøy T, Bolann BJ, Thorsen E. Reduced nitric oxide concentration in exhaled gas after exposure to hyperbaric hyperoxia. Undersea Hyperb Med. 2007; 34: 321-327.
24. Joëls M. Stress, the hippocampus, and epilepsy. Epilepsia. 2009; 50: 586-597.
25. Leung LS, Wu K. Epilepsy-based changes in hippocampal excitability: causes and effects. Adv Neurol. 2006; 97: 63-68.
26. Clark JM, Lambertsen CJ. Pulmonary oxygen toxicity: a review. Pharmacol Rev. 1971; 23: 37-133.
27. Smith QR, Rapoport SI. Cerebrovascular permeability coefficients to sodium, potassium, and chloride. J Neurochem. 1986; 46: 1732-1742.